The first time I saw an advertisement for osteoporosis, I was a little surprised. The screen was very young Sally Field talks about once a month pill to restore bone loss. So I was surprised because in the U.S. working group on prevention is not recommended to get screened for osteoporosis until you are 65 years or if you are "young women whose risk of fracture is equal to or greater than 65-year old ... "
Why pharmaceutical companies using this type of young actresses to promote the drug, designed primarily for people older than her? The reason is simple. It's all about market expansion. Numbers vary widely, but a conservative estimate that about 8 million American women suffer from osteoporosis. This is a healthy market for any drug. But what if it could be expanded to include people who were in the
risk of osteoporosis? Sell it to young women as a preventive care, and you will quickly increase the market more than 20 or 30 million potential users. All pharmaceutical companies want the word that they could build their "to osteoporosis" marketing campaign around. Word that they found "osteopenia."
Let's go back in time to 1992. World Health Organization convened a panel of experts in Rome to understand the problem of osteoporosis. They wanted to figure out how to identify women who are at risk
before they were destroying. Eventually they settled on the so-called T-score that compares the bone density Rights, and healthy young adult woman. Then they created a category, these estimates may fall. Categories range from normal to severe osteoporosis.
For people in the middle of the range lasix 180 mg, they decided to use the term "osteopenia".
Word osteopenia (which means "bone deficit") and was not intended for use as a diagnosis. It was just a way to determine which categories were the objects of study. But pharmaceutical companies have started to promote it as if it were a new disease, and they were the only drugs to take care of it. They are called bisphosphonates; Fosamax and Boniva are the two most prominent. In 1997, Merck submitted studies FDA justifies the lower dose of Fosamax version to be used as preventive medicine for postmenopausal women in
risk of osteoporosis. The word "osteopenia," invented in 1992, which met in Rome, was used as a diagnosis of disease and sales increased. There was only one small problem. Over the past 15 years no studies that show taking bisphosphonates prevent bone breaks 10, 20 or 30 years in the future. The only benefit was shown for people who are diagnosed with osteoporosis. Slowly the dark side began to emerge. Users experiencing side effects like heartburn, indigestion, heartburn, inflammation of the eye vision damage and severe muscle and joint pain. British researchers found that taking drugs for three to five years doubles the risk of developing esophageal cancer. In rare cases, some people felt the horror of osteonecrosis, a condition where the jaw bone decay and the patient dies. Perhaps the most devastating side effect is that prolonged use of women who have osteoporosis may lead to a weakening of bones! How bisphosphonates work, slowing down the cells that destroy bone. (These cells are called osteoclasts.) The problem is that, interrupting the normal cycle in the body repair and demolition, no stress breaks our body is going through will not heal properly. Tests show that these drugs actually help build bone in the first five years, but for more than that the bones may actually become more brittle. In May 2011 the Swedish researchers reviewed data on about 1. 52000000 Women. They found that women taking bisphosphonates longest was the highest risk of hip fractures. So you have to do? Next week we will tell you who should be tested, who on more risk and what you can do to build stronger bones. Note: Before beginning any diet or exercise, consult your doctor or health care provider first. For a Free Consultation from WeBeFit call coach (305) 296-3434. More articles on the website WWW. WeBeFit. com. . << >>
No comments:
Post a Comment